An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Non Hodgkin Lymphoma

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Curis

Protocol Number
CA-4948-101

To Learn More Call
(201)-510-0950